PYRAZOLOPYRIDAZINDERIVATE

European patent · EP1463730 · Deleted

Register entry

Publication number
EP1463730
Application number
EP02805104
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 11, 2002
Published
Oct 6, 2004
Granted
Apr 19, 2006
Deleted
Apr 19, 2006
Reason
No effect for Switzerland and Liechtenstein
IPC classes
C07D 487/04 (2006.01)
A61K 31/5025 (2006.01)
A61P 35/00 (2006.01)
//C07D 487/04 (2006.01)
//C07D 237/00 (2006.01)
//C07D 231/00 (2006.01)
Priority
US 341798 P 17.12.2001
PCT application
PCT/US2002/039672 11.12.2002
PCT publication
WO2003/051886 26.06.2003
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 31, 2006

    Change

    Published in +pat+ No 20 in 2006

  2. Apr 28, 2006

    Granted

    Published in +pat+ No 8 in 2006

Parties

Inventor

HARRIS, Phillip Anthony, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

JUNG, David Kendall, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

PEEL, Michael Robert, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

RENO, Michael John, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

RHEAULT, Tara Renae, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

BADIANG, Jennifer, G, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

STEVENS, Kirk Lawrence, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

VEAL, James Marvin, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

TAVARES, Francis, Xavier

Research Triangle Park, NC 27709, US

DICKERSON, Scott Howard, GlaxoSmithKline

Research Triangle Park, NC 27709, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.